Literature DB >> 8422705

A spontaneous subcutaneous tumor in C57BL/6 mice that metastasizes to the liver.

S D Nathanson1, L T Nelson, M Lee.   

Abstract

A malignant tumor that arose spontaneously in the subcutaneous tissue of the back of a C57BL/6 female mouse was found to metastasize spontaneously to the liver. The primary and metastatic tumors, SML (spontaneous metastasis to the liver) 1 and SML 2, were established in vitro in long-term cell suspension culture and were passaged 10 times in vivo for 18 months. When 100,000 cells were injected subcutaneously in the orthotopic position, tumor growth appeared in 60% of the SML 1 mice and 100% of the SML 2 mice. SML 1 did not grow when injected in the footpad, while SML 2 did. The median survival was 47 days for SML 1 and 48.5 days for SML 2 (P = 0.013). The pattern of metastasis was similar for both tumor cell lines, irrespective of intravenous or subcutaneous injection routes. Spontaneous metastasis of the SML 2 line occurred from both the orthotopic and heterotopic sites, while the SML 1 metastasized spontaneously from the orthotopic site only. Liver metastasis appeared in > 90% of the mice for both SML 1 and SML 2. Metastasis to the spleen occurred in about half the mice. Other sites of metastasis were the ovaries (36% and 52%, respectively, for SML 1 and SML 2), the kidneys (approximately 15%) and the small bowel (very rarely). Metastasis to the lungs did not occur except very rarely in the later passages of the SML 2 line. Histologic, immunohistochemical and electron microscopic studies showed a histiocytic tumor with macrophage characteristics. The cells exhibited chemotaxis toward liver extracellular matrix and reduced motility toward collagen IV, laminin and fibronectin compared to the B16-F10 melanoma line. This spontaneously occurring tumor should prove useful for the study of organ-specific metastasis to the liver.

Entities:  

Mesh:

Year:  1993        PMID: 8422705     DOI: 10.1007/bf00880065

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  22 in total

1.  Organ-specific chemotactic factors present in lung extracellular matrix.

Authors:  R F Cerra; S D Nathanson
Journal:  J Surg Res       Date:  1989-05       Impact factor: 2.192

2.  Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain.

Authors:  R S Kerbel; R R Twiddy; D M Robertson
Journal:  Int J Cancer       Date:  1978-11-15       Impact factor: 7.396

3.  Characterization of a deficiency in fucose metabolism in lectin-resistant variants of a murine tumor showing altered tumorigenic and metastatic capacities in vivo.

Authors:  J W Dennis; R S Kerbel
Journal:  Cancer Res       Date:  1981-01       Impact factor: 12.701

4.  Random and nonrandom processes in metastasis, and metastatic inefficiency.

Authors:  L Weiss
Journal:  Invasion Metastasis       Date:  1983

5.  Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis.

Authors:  K M Miner; G L Nicolson
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

Review 6.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

7.  Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth.

Authors:  I R Hart; J E Talmadge; I J Fidler
Journal:  Cancer Res       Date:  1981-04       Impact factor: 12.701

8.  Selection for virulence and organ-specific metastasis of herpesvirus-transformed lymphoma cells.

Authors:  P J Shearman; B M Longenecker
Journal:  Int J Cancer       Date:  1980-03-15       Impact factor: 7.396

9.  Liver-colonizing melanoma cells selected from B-16 melanoma.

Authors:  T Tao; A Matter; K Vogel; M M Burger
Journal:  Int J Cancer       Date:  1979-06-15       Impact factor: 7.396

10.  Radioimmunodetection of murine mammary adenocarcinoma (TA3/Ha) lung and liver metastases with radioiodinated PNA.

Authors:  A Shysh; S M Eu; A A Noujaim; M R Suresh; B M Longenecker
Journal:  Int J Cancer       Date:  1985-01-15       Impact factor: 7.396

View more
  6 in total

1.  Viral RNA trafficking is inhibited in replicase-mediated resistant transgenic tobacco plants.

Authors:  L Nguyen; W J Lucas; B Ding; M Zaitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Invasion of minor veins of tobacco leaves inoculated with tobacco mosaic virus mutants defective in phloem-dependent movement.

Authors:  X Ding; M H Shintaku; S A Carter; R S Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

3.  A novel naturally occurring hybrid gene encoded by a plant RNA virus facilitates long distance virus movement.

Authors:  S W Ding; W X Li; R H Symons
Journal:  EMBO J       Date:  1995-12-01       Impact factor: 11.598

4.  The biological sense of cancer: a hypothesis.

Authors:  Raúl A Ruggiero; Oscar D Bustuoabad
Journal:  Theor Biol Med Model       Date:  2006-12-15       Impact factor: 2.432

5.  Aphid transmission of beet western yellows luteovirus requires the minor capsid read-through protein P74.

Authors:  V Brault; J F van den Heuvel; M Verbeek; V Ziegler-Graff; A Reutenauer; E Herrbach; J C Garaud; H Guilley; K Richards; G Jonard
Journal:  EMBO J       Date:  1995-02-15       Impact factor: 11.598

6.  Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment.

Authors:  Sebastian A Wohlfeil; Verena Häfele; Bianca Dietsch; Céline Weller; Carsten Sticht; Anna Sophia Jauch; Manuel Winkler; Christian David Schmid; Anna Lena Irkens; Ana Olsavszky; Kai Schledzewski; Philipp-Sebastian Reiners-Koch; Sergij Goerdt; Cyrill Géraud
Journal:  J Transl Med       Date:  2022-02-02       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.